Literature DB >> 15951183

An approach toward the problem of outliers in QSAR.

Rajeshwar P Verma1, Corwin Hansch.   

Abstract

Compounds that have unexpected biological activity and are unable to fit in a QSAR model are known as outliers. These are valuable in defining the limitations under which compounds act by a common molecular mechanism modeled by one or more descriptors, and also in defining the experimental limitations of the biological test data. Thus, the outliers should be submitted to particular attention to see if the reason for their peculiarity can be determined. Separating these outliers from the main data set and formulating another QSAR can resolve the problem. Our result shows that these outliers may be acting by a different mechanism or interacting with the receptor in different modes.

Mesh:

Substances:

Year:  2005        PMID: 15951183     DOI: 10.1016/j.bmc.2005.05.002

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  9 in total

Review 1.  In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling.

Authors:  S Ekins; J Mestres; B Testa
Journal:  Br J Pharmacol       Date:  2007-06-04       Impact factor: 8.739

Review 2.  How medicinal chemists learned about log P.

Authors:  Yvonne Connolly Martin
Journal:  J Comput Aided Mol Des       Date:  2018-07-17       Impact factor: 3.686

3.  Outliers in SAR and QSAR: 4. effects of allosteric protein-ligand interactions on the classical quantitative structure-activity relationships.

Authors:  Ki Hwan Kim
Journal:  Mol Divers       Date:  2022-02-22       Impact factor: 3.364

4.  Outliers in SAR and QSAR: 3. Importance of considering the role of water molecules in protein-ligand interactions and quantitative structure-activity relationship studies.

Authors:  Ki Hwan Kim
Journal:  J Comput Aided Mol Des       Date:  2021-03-13       Impact factor: 3.686

5.  Discovery of potent Covid-19 main protease inhibitors using integrated drug-repurposing strategy.

Authors:  Muthu Kumar T; Rohini K; Nivya James; Shanthi V; Ramanathan K
Journal:  Biotechnol Appl Biochem       Date:  2021-04-14       Impact factor: 2.724

6.  Exploring the ligand-protein networks in traditional chinese medicine: current databases, methods and applications.

Authors:  Mingzhu Zhao; Dongqing Wei
Journal:  Adv Exp Med Biol       Date:  2015       Impact factor: 2.622

7.  Exploring the ligand-protein networks in traditional chinese medicine: current databases, methods, and applications.

Authors:  Mingzhu Zhao; Qiang Zhou; Wanghao Ma; Dong-Qing Wei
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-02       Impact factor: 2.629

8.  Insight into the Structural Determinants of Imidazole Scaffold-Based Derivatives as TNF-α Release Inhibitors by in Silico Explorations.

Authors:  Yuan Wang; Mingwei Wu; Chunzhi Ai; Yonghua Wang
Journal:  Int J Mol Sci       Date:  2015-08-25       Impact factor: 5.923

9.  Study of the Differential Activity of Thrombin Inhibitors Using Docking, QSAR, Molecular Dynamics, and MM-GBSA.

Authors:  Karel Mena-Ulecia; William Tiznado; Julio Caballero
Journal:  PLoS One       Date:  2015-11-24       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.